290 related articles for article (PubMed ID: 18782656)
1. Aromatase inhibitor-induced joint pain: melatonin's role.
Burk R
Med Hypotheses; 2008 Dec; 71(6):862-7. PubMed ID: 18782656
[TBL] [Abstract][Full Text] [Related]
2. Aromatase inhibitor-associated arthralgia syndrome.
Burstein HJ
Breast; 2007 Jun; 16(3):223-34. PubMed ID: 17368903
[TBL] [Abstract][Full Text] [Related]
3. Human pineal physiology and functional significance of melatonin.
Macchi MM; Bruce JN
Front Neuroendocrinol; 2004; 25(3-4):177-95. PubMed ID: 15589268
[TBL] [Abstract][Full Text] [Related]
4. Estrogen-signaling pathway: a link between breast cancer and melatonin oncostatic actions.
Cos S; González A; Martínez-Campa C; Mediavilla MD; Alonso-González C; Sánchez-Barceló EJ
Cancer Detect Prev; 2006; 30(2):118-28. PubMed ID: 16647824
[TBL] [Abstract][Full Text] [Related]
5. Circadian rhythms and arthritis.
Cutolo M; Masi AT
Rheum Dis Clin North Am; 2005 Feb; 31(1):115-29, ix-x. PubMed ID: 15639059
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for early-stage breast cancer.
Crew KD; Greenlee H; Capodice J; Raptis G; Brafman L; Fuentes D; Sierra A; Hershman DL
J Clin Oncol; 2007 Sep; 25(25):3877-83. PubMed ID: 17761973
[TBL] [Abstract][Full Text] [Related]
7. Lighting for the human circadian clock: recent research indicates that lighting has become a public health issue.
Pauley SM
Med Hypotheses; 2004; 63(4):588-96. PubMed ID: 15325001
[TBL] [Abstract][Full Text] [Related]
8. Aromatase inhibitor-induced arthralgia: clinical experience and treatment recommendations.
Coleman RE; Bolten WW; Lansdown M; Dale S; Jackisch C; Merkel D; Maass N; Hadji P
Cancer Treat Rev; 2008 May; 34(3):275-82. PubMed ID: 18082328
[TBL] [Abstract][Full Text] [Related]
9. Randomized, blinded, sham-controlled trial of acupuncture for the management of aromatase inhibitor-associated joint symptoms in women with early-stage breast cancer.
Crew KD; Capodice JL; Greenlee H; Brafman L; Fuentes D; Awad D; Yann Tsai W; Hershman DL
J Clin Oncol; 2010 Mar; 28(7):1154-60. PubMed ID: 20100963
[TBL] [Abstract][Full Text] [Related]
10. Short-term and low-dose prednisolone administration reduces aromatase inhibitor-induced arthralgia in patients with breast cancer.
Kubo M; Onishi H; Kuroki S; Okido M; Shimada K; Yokohata K; Umeda S; Ogawa T; Tanaka M; Katano M
Anticancer Res; 2012 Jun; 32(6):2331-6. PubMed ID: 22641670
[TBL] [Abstract][Full Text] [Related]
11. Light, dark, and melatonin: emerging evidence for the importance of melatonin in ocular physiology.
Brennan R; Jan JE; Lyons CJ
Eye (Lond); 2007 Jul; 21(7):901-8. PubMed ID: 17001324
[TBL] [Abstract][Full Text] [Related]
12. Melatonin, environmental light, and breast cancer.
Srinivasan V; Spence DW; Pandi-Perumal SR; Trakht I; Esquifino AI; Cardinali DP; Maestroni GJ
Breast Cancer Res Treat; 2008 Apr; 108(3):339-50. PubMed ID: 17541739
[TBL] [Abstract][Full Text] [Related]
13. Sonographic and electrodiagnostic evaluations in patients with aromatase inhibitor-related arthralgia.
Dizdar O; Ozçakar L; Malas FU; Harputluoglu H; Bulut N; Aksoy S; Ozisik Y; Altundag K
J Clin Oncol; 2009 Oct; 27(30):4955-60. PubMed ID: 19752344
[TBL] [Abstract][Full Text] [Related]
14. Prospective study to assess short-term intra-articular and tenosynovial changes in the aromatase inhibitor-associated arthralgia syndrome.
Morales L; Pans S; Verschueren K; Van Calster B; Paridaens R; Westhovens R; Timmerman D; De Smet L; Vergote I; Christiaens MR; Neven P
J Clin Oncol; 2008 Jul; 26(19):3147-52. PubMed ID: 18474874
[TBL] [Abstract][Full Text] [Related]
15. Classification of and risk factors for estrogen deprivation pain syndromes related to aromatase inhibitor treatments in women with breast cancer: a prospective multicenter cohort study.
Laroche F; Coste J; Medkour T; Cottu PH; Pierga JY; Lotz JP; Beerblock K; Tournigand C; Declèves X; de Cremoux P; Bouhassira D; Perrot S
J Pain; 2014 Mar; 15(3):293-303. PubMed ID: 24365325
[TBL] [Abstract][Full Text] [Related]
16. Altered circadian rhythms in rheumatoid arthritis patients play a role in the disease's symptoms.
Cutolo M; Villaggio B; Otsa K; Aakre O; Sulli A; Seriolo B
Autoimmun Rev; 2005 Nov; 4(8):497-502. PubMed ID: 16214085
[TBL] [Abstract][Full Text] [Related]
17. Joint pain with aromatase inhibitors: abnormal frequency of Sjögren's syndrome.
Laroche M; Borg S; Lassoued S; De Lafontan B; Roché H
J Rheumatol; 2007 Nov; 34(11):2259-63. PubMed ID: 17937464
[TBL] [Abstract][Full Text] [Related]
18. Melatonin: Nature's most versatile biological signal?
Pandi-Perumal SR; Srinivasan V; Maestroni GJ; Cardinali DP; Poeggeler B; Hardeland R
FEBS J; 2006 Jul; 273(13):2813-38. PubMed ID: 16817850
[TBL] [Abstract][Full Text] [Related]
19. Aromatase inhibitor-associated arthralgia and/ or bone pain: frequency and characterization in non-clinical trial patients.
Presant CA; Bosserman L; Young T; Vakil M; Horns R; Upadhyaya G; Ebrahimi B; Yeon C; Howard F
Clin Breast Cancer; 2007 Oct; 7(10):775-8. PubMed ID: 18021478
[TBL] [Abstract][Full Text] [Related]
20. Feasibility and promise of a 6-week program to encourage physical activity and reduce joint symptoms among elderly breast cancer survivors on aromatase inhibitor therapy.
Nyrop KA; Muss HB; Hackney B; Cleveland R; Altpeter M; Callahan LF
J Geriatr Oncol; 2014 Apr; 5(2):148-55. PubMed ID: 24495696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
